# Novan, Inc.: Form D filings

Novan, Inc., a biotechnology company in Durham, NC, filed 12 Form D notices with the SEC between 2009 and 2015. The latest, on December 30, 2015, reports $32.8 million sold of a $32.8 million offering to 172 investors.

Find out what Novan, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Novan%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Novan%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnovan-inc-1467154)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Novan%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Novan%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnovan-inc-1467154)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4222 EMPEROR BLVD, SUITE 200, Durham, NC, 27703
- Phone: (919) 485-8080
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1467154

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 30, 2015 | Amendment | $32,840,304 | $32,840,304 | $0 | 172 | Dec 1, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715415000003/0001467154-15-000003-index.htm) |
| Dec 16, 2015 | New notice | $31,000,000 | $30,409,735 | $590,265 | 146 | Dec 1, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715415000002/0001467154-15-000002-index.htm) |
| Mar 30, 2015 | Amendment | $50,000,008 | $50,000,008 | $0 | 91 | Aug 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715415000001/0001467154-15-000001-index.htm) |
| Aug 29, 2014 | New notice | $25,000,000 | $10,325,093 | $14,674,907 | 61 | Aug 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715414000003/0001467154-14-000003-index.htm) |
| Mar 10, 2014 | New notice | $3,502,125 | $3,502,125 | $0 | 36 | Feb 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715414000001/0001467154-14-000001-index.htm) |
| Feb 28, 2013 | Amendment | $11,000,000 | $11,000,000 | $0 | 50 | Apr 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715413000001/0001467154-13-000001-index.htm) |
| May 31, 2012 | New notice | $5,170,000 | $5,170,000 | $0 | 17 | Apr 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715412000002/0001467154-12-000002-index.htm) |
| Sep 29, 2011 | Amendment | $5,999,989 | $5,999,968 | $21 | 12 | Nov 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715411000003/0001467154-11-000003-index.htm) |
| Aug 29, 2011 | Amendment | $5,999,989 | $5,599,986 | $400,003 | 11 | Nov 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715411000002/0001467154-11-000002-index.htm) |
| Jan 18, 2011 | Amendment | $3,999,992 | $3,999,992 | $0 | 9 | Nov 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715411000001/0001467154-11-000001-index.htm) |
| Nov 18, 2010 | New notice | $3,999,992 | $3,049,994 | $949,998 | 9 | Nov 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715410000001/0001467154-10-000001-index.htm) |
| Jul 2, 2009 | New notice | $2,000,000 | $2,000,000 | $0 | 5 | Jul 1, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467154/000146715409000001/0001467154-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mark Schoenfisch | Director |  |
| G. Kelly Martin | Director |  |
| Sean Kelly Murphy | Director |  |
| F Neal Hunter | Director |  |
| W. Kent Geer | Director |  |
| John W Palmour | Director |  |
| Richard Kelly Peterson | Executive Officer |  |
| Robert A Ingram | Director |  |
| Nathan Stasko | Executive Officer, Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Dec 28, 2015](https://specstream.ai/data/form-d/week/2015-12-28) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Novan, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).